Krystal Biotech Inc (KRYS)
199.30
+13.85
(+7.47%)
USD |
NASDAQ |
Nov 08, 16:00
199.30
0.00 (0.00%)
After-Hours: 16:00
Krystal Biotech Revenue (Annual): 50.70M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 50.70M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
50.70M
Minimum
2023
50.70M
Maximum
2023
50.70M
Average
50.70M
Median
2023
Revenue (Annual) Benchmarks
| Bioventus Inc | 512.34M |
| ADMA Biologics Inc | 258.22M |
| Axsome Therapeutics Inc | 270.60M |
| Amicus Therapeutics Inc | 399.36M |
| Sarepta Therapeutics Inc | 1.243B |